Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to -$21.3 million.

  • Collegium Pharmaceutical's Other Working Capital Changes fell 501635.94% to -$21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 8386.01%. This contributed to the annual value of $14.1 million for FY2024, which is 107776.23% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Other Working Capital Changes of -$21.3 million as of Q3 2025, which was down 501635.94% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Other Working Capital Changes registered a high of $11.5 million during Q2 2024, and its lowest value of -$21.3 million during Q3 2025.
  • Over the past 5 years, Collegium Pharmaceutical's median Other Working Capital Changes value was $432000.0 (recorded in 2022), while the average stood at $952947.4.
  • Within the past 5 years, the most significant YoY rise in Collegium Pharmaceutical's Other Working Capital Changes was 570338.98% (2025), while the steepest drop was 501635.94% (2025).
  • Over the past 5 years, Collegium Pharmaceutical's Other Working Capital Changes (Quarter) stood at $2.3 million in 2021, then surged by 141.97% to $5.6 million in 2022, then crashed by 124.93% to -$1.4 million in 2023, then surged by 239.44% to $1.9 million in 2024, then plummeted by 1195.33% to -$21.3 million in 2025.
  • Its last three reported values are -$21.3 million in Q3 2025, $10.8 million for Q2 2025, and $10.3 million during Q1 2025.